The University of Maryland BioPark announced today that Fluxome Inc., a nutraceutical ingredient company using novel metabolic engineering and fermentation methods, is the newest company to join the growing community of commercial tenants at the BioPark. According to Fluxome’s lease with building owner Wexford Science & Technology, LLC, Fluxome has based its U.S. headquarters and commercial operations in the BioPark building at 801 West Baltimore Street in Baltimore.
Said Jane Shaab, University of Maryland Research Park Corporation Senior Vice President, “It’s exciting to have another international tenant join us and it is especially rewarding to welcome Fluxome’s President and CEO Angela Tsetsis, who was previously on the management team at Columbia-based Martek (now Royal DSM N.V.), back to Maryland’s business community. Under Angela’s leadership, Fluxome is an example of a next-generation Maryland life sciences company.”